Topical Discussions
Discussing the SMART Trial: TAVR Patients With Small Aortic Annuli
Rahul P. Sharma speaks with Vinod Thourani, Suzanne Baron, and Philippe Généreux about what the results indicate for long-term management and TAVR durability in this population.
TCTMD's Quick Takes: Megan Coylewright
It’s important for clinical trials to reflect the populations they’re designed to serve—Megan Coylewright, MD, outlines why diversity matters and how trialists can make a difference.
TCTMD's Quick Takes: Amole Ojo
Digoxin’s risks in HFrEF patients with ICDs are well-known, but the magnitude may surprise, Amole Ojo, MD, explains.